Closing Figures: Sangamo Therapeutics Inc (SGMO)’s Positive Finish at 0.87, Up 2.66

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $0.84 in the prior trading day, Sangamo Therapeutics Inc (NASDAQ: SGMO) closed at $0.87, up 2.66%. In other words, the price has increased by $2.66 from its previous closing price. On the day, 1.56 million shares were traded. SGMO stock price reached its highest trading level at $0.8891 during the session, while it also had its lowest trading level at $0.84.

Ratios:

Our goal is to gain a better understanding of SGMO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.23.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on November 03, 2023, Downgraded its rating to Sector Perform and sets its target price to $2 from $6 previously.

On April 28, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $5 to $1.50.

Wedbush Upgraded its Neutral to Outperform on February 27, 2023, while the target price for the stock was maintained at $16.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMO now has a Market Capitalization of 180631712 and an Enterprise Value of 181838320. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.70 while its Price-to-Book (P/B) ratio in mrq is 7.62. Its current Enterprise Value per Revenue stands at 14.811 whereas that against EBITDA is -0.983.

Stock Price History:

Over the past 52 weeks, SGMO has reached a high of $1.48, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 6.84%, while the 200-Day Moving Average is calculated to be 33.69%.

Shares Statistics:

The stock has traded on average 14.54M shares per day over the past 3-months and 2876290 shares per day over the last 10 days, according to various share statistics. A total of 208.22M shares are outstanding, with a floating share count of 198.84M. Insiders hold about 4.51% of the company’s shares, while institutions hold 41.89% stake in the company. Shares short for SGMO as of 1726185600 were 17504104 with a Short Ratio of 1.20, compared to 1723680000 on 16093755. Therefore, it implies a Short% of Shares Outstanding of 17504104 and a Short% of Float of 8.450000000000001.

Most Popular